highly significantp value <0.001
When comparing FVIII inhibitor development over the period of 2009–2015 (24%) to the period of 2016–2022 (16%), this difference was highly significant ( p value <0.001).
When comparing FVIII inhibitor development over the period of 2009–2015 (24%) to the period of 2016–2022 (16%), this difference was highly significant ( p value <0.001).